Valeant said ISTA refused to enter into a confidentiality agreement when it first approached the company about an acquisition in October, and subsequently rejected a written proposal, so Valeant has decided to make an unsolicited offer to shareholders.
FORBES: Pharma News: Valeant Bids for ISTA, Pfizer Announces Study Results, Vaccine Pact